114 related articles for article (PubMed ID: 3173919)
1. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
Vermesh M; Fossum GT; Kletzky OA
Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating levels of bromocriptine after vaginal compared with oral administration.
Katz E; Weiss BE; Hassell A; Schran HF; Adashi EY
Fertil Steril; 1991 May; 55(5):882-4. PubMed ID: 2022266
[TBL] [Abstract][Full Text] [Related]
3. Prolactin (PRL) response to oral or vaginal bromoergocriptine in hyperprolactinemic women.
Dash RJ; Ajmani AK; Sialy R
Horm Metab Res; 1994 Mar; 26(3):164. PubMed ID: 8005568
[No Abstract] [Full Text] [Related]
4. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
Kletzky OA; Vermesh M
Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
[TBL] [Abstract][Full Text] [Related]
5. Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women.
Cicinelli E; Cignarelli M; Petruzzi D; Matteo MG; Ruccia C; Schonauer LM
J Endocrinol Invest; 1996; 19(7):427-32. PubMed ID: 8884536
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
7. [Puerperal inhibition of lactation with metergoline or bromocriptine].
Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
[TBL] [Abstract][Full Text] [Related]
8. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy.
Katz E; Schran HF; Adashi EY
Obstet Gynecol; 1989 Mar; 73(3 Pt 2):517-20. PubMed ID: 2915884
[TBL] [Abstract][Full Text] [Related]
11. Vaginal bromocriptine--clinical and biochemical effects.
Ginsburg J; Hardiman P; Thomas M
Gynecol Endocrinol; 1992 Jun; 6(2):119-26. PubMed ID: 1502929
[TBL] [Abstract][Full Text] [Related]
12. Superiority of newly developed vaginal suppositories over vaginal use of commercial bromocriptine tablets: a randomized controlled clinical trial.
Darwish AM; Farah E; Gadallah WA; Mohammad II
Reprod Sci; 2007 Apr; 14(3):280-5. PubMed ID: 17636242
[TBL] [Abstract][Full Text] [Related]
13. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lactation by a long-acting bromocriptine.
Peters F; Del Pozo E; Conti A; Breckwoldt M
Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
[TBL] [Abstract][Full Text] [Related]
15. A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor.
How HY; Leaseburge L; Khoury JC; Siddiqi TA; Spinnato JA; Sibai BM
Am J Obstet Gynecol; 2001 Oct; 185(4):911-5. PubMed ID: 11641677
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
[TBL] [Abstract][Full Text] [Related]
17. Experimental hyperprolactinemia and hypoprolactinemia and human chorionic gonadotropin during early pregnancy.
Viinikka L; Kivinen S; Rönnberg L; Ylikorkala O
Obstet Gynecol; 1981 Apr; 57(4):441-3. PubMed ID: 7243090
[TBL] [Abstract][Full Text] [Related]
18. [Parenteral, depot and repeatable forms of Parlodel LAR bromocriptine in the treatment of hyperprolactinemia syndrome. Comparison with oral Parlodel].
Dolecek R; Lancranjanová I; Putz Z; Vavros D; Závada M
Cas Lek Cesk; 1993 Feb; 132(3):81-5. PubMed ID: 8458069
[TBL] [Abstract][Full Text] [Related]
19. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
20. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M
No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
